Drug prices in Latin American countries: the case of rheumatoid arthritis Biosimilars

Drug prices in Latin American countries: the case of rheumatoid arthritis Biosimilars

Abstract Background The objective of this paper is to analyze the prices of biological drugs in the treatment of Rheumatoid Arthritis (RA) in three Latin American countries (Brazil, Colombia and Mexico), as well as in Spain and the United States of America (US), from the point of market entry of bio...

Full description

Bibliographic Details
Main Authors: Gabriela Bittencourt Gonzalez Mosegui, Fernando Antõnanzas, Cid Manso de Mello Vianna, Paula Rojas
Format: Article
Language:English
Published: BMC 2021-02-01
Series:Advances in Rheumatology
Subjects:
Biological products
Antirheumatic agents
Access to essential medicines and health technologies
Products registration
Drug Price
Online Access:https://doi.org/10.1186/s42358-021-00172-w

Internet

https://doi.org/10.1186/s42358-021-00172-w

Similar Items